Graft Failure Due to Noncompliance Among 628 Kidney Transplant Recipients With Long-term Follow-up: A Single-Center Observational Study

被引:59
作者
Gaynor, Jeffrey J. [1 ]
Ciancio, Gaetano [1 ]
Guerra, Giselle [2 ]
Sageshima, Junichiro [1 ]
Hanson, Lois [1 ]
Roth, David [2 ]
Chen, Linda [1 ]
Kupin, Warren [2 ]
Mattiazzi, Adela [2 ]
Tueros, Lissett [1 ]
Flores, Sandra [1 ]
Aminsharifi, Jason [1 ]
Joshi, Shivam [1 ]
Chediak, Zoila [1 ]
Ruiz, Phillip [1 ]
Vianna, Rodrigo [1 ]
Burke, George W., III [1 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Surg, Miami Transplant Inst, Miami, FL 33101 USA
[2] Univ Miami, Miller Sch Med, Dept Med, Miami Transplant Inst, Miami, FL 33101 USA
关键词
Kidney transplantation; Graft failure due to noncompliance; Cause-specific graft loss; Prognostic factors; RENAL-ALLOGRAFT SURVIVAL; DOSE MAINTENANCE IMMUNOSUPPRESSION; RANDOMIZED-TRIAL; UNITED-STATES; PATIENT NONCOMPLIANCE; COMPETING RISKS; NONADHERENCE; CYCLOSPORINE; REJECTION; PROGRESS;
D O I
10.1097/01.TP.0000438199.76531.4a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background In adult kidney transplantation, there is no clear consensus on the incidence of graft failure-due-to noncompliance (GFNC), with some reporting it as relatively uncommon and others as a major cause of late graft failure. We suspected that GFNC was a major cause of late graft loss at our center but did not know the extent of this problem. Methods In our prospectively followed cohort of 628 adult, primary kidney-alone transplant recipients with long-term follow-up, GFNC and other graft loss causes were determined from our ongoing clinical evaluations. Using competing risks methodology, we determined the overall percentage of patients developing GFNC and the significant prognostic factors for its hazard rate and cumulative incidence (via Cox regression). Results Cumulative incidence estimates (standard error) of GFNC (n=29), GF-with-compliance (n=46), receiving a never-functioning graft (n=7), and death-with-a-functioning-graft (n=53) at 101 months after transplant (last-observed-graft loss) were as follows: 9.8%+/- 2.4%, 10.9%+/- 1.7%, 1.1%+/- 0.4%, and 13.0%+/- 1.9%, respectively. Only three patients experienced GFNC during the first 24 months; GFNC represented 48.1% (26/54) of death-censored GFs beyond 24 months. Two baseline variables were jointly associated with a significantly higher GFNC hazard and cumulative incidence: younger recipient age (P<0.000001 each) and non-white recipient (P=0.004 and P=0.02). Estimated percentages of ever developing GFNC were 28.4%+/- 6.5% among 79 non-whites younger than 35 years versus 0.0% (0/144) among whites 50 years or older. Among 302 recipients younger than 50 years, 18.1%+/- 4.1% developed GFNC, representing 67.6% (25/37) of its death-censored graft failures observed beyond 24 months after transplant. Conclusions GFNC is a major cause of late GF at our center, with younger and non-white recipients at a significantly greater GFNC risk. Interventional approaches to eliminate GFNC could dramatically improve long-term kidney graft survival.
引用
收藏
页码:925 / 933
页数:9
相关论文
共 50 条
[41]   Long-term mortality among kidney transplant recipients with and without diabetes: a nationwide cohort study in the USA [J].
Harding, Jessica L. ;
Pavkov, Meda ;
Wang, Zhensheng ;
Benoit, Stephen ;
Burrows, Nilka Rios ;
Imperatore, Giuseppina ;
Albright, Ann L. ;
Patzer, Rachel .
BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
[42]   Everolimus and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Registry-based 10-year Follow-up of 5 Randomized Trials [J].
Ying, Tracey ;
Wong, Germaine ;
Lim, Wai H. ;
Clayton, Philip ;
Kanellis, John ;
Pilmore, Helen ;
Campbell, Scott ;
O'Connell, Philip J. ;
Russ, Graeme ;
Chadban, Steven .
TRANSPLANTATION, 2019, 103 (08) :1705-1713
[43]   Long-Term Follow-up Results of Renal Transplantation in Pediatric Patients With Focal Segmental Glomerulosclerosis: A Single-Center Experience [J].
Bulut, I. K. ;
Taner, S. ;
Keskinoglu, A. ;
Toz, H. ;
Sarsik, B. ;
Sezer, T. O. ;
Kabasakal, C. .
TRANSPLANTATION PROCEEDINGS, 2019, 51 (04) :1064-1069
[44]   Long-term follow-up of hepatitis C virus infection among organ transplant recipients - Implications for policies on organ procurement [J].
Bouthot, BA ;
Murthy, BVR ;
Schmid, CH ;
Levey, AS ;
Pereira, BJG .
TRANSPLANTATION, 1997, 63 (06) :849-853
[45]   Health-Related Quality of Life and Long-Term Survival and Graft Failure in Kidney Transplantation: A 12-Year Follow-Up Study [J].
Griva, Konstadina ;
Davenport, Andrew ;
Newman, Stanton P. .
TRANSPLANTATION, 2013, 95 (05) :740-749
[46]   Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up [J].
Tillmann, F. P. ;
Schmitz, M. ;
Jaeger, M. ;
Krauspe, R. ;
Rump, L. C. .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (02) :279-286
[47]   Long-Term Study of Steroid Avoidance in Renal Transplant Patients: A Single-Center Experience [J].
Nagi, A. M. ;
Abbas, M. H. ;
Abu-Elmagd, M. M. ;
Denewar, A. A. E. F. ;
Neamatalla, A. H. ;
Refaie, A. F. ;
Bakr, M. A. .
TRANSPLANTATION PROCEEDINGS, 2015, 47 (04) :1099-1104
[48]   Long-term outcomes in rapamycin on renal allograft function: a 30-year follow-up from a single-center experience [J].
Ji, Yisheng ;
Sun, Li ;
Fei, Shuang ;
Gao, Xiang ;
Chen, Hao ;
Han, Zhijian ;
Tao, Jun ;
Ju, Xiaobing ;
Wang, Zijie ;
Tan, Ruoyun ;
Gu, Min .
BMC NEPHROLOGY, 2024, 25 (01)
[49]   Long-term Outcome of Pediatric Liver Transplant Recipients Who Have Reached Adulthood: A Single-center Experience [J].
Lund, Louisa Katharina ;
Grabhorn, Enke Freya ;
Ruether, Darius ;
Buchholz, Angela ;
Lang, Melanie ;
Herden, Uta ;
Fischer, Lutz ;
Sterneck, Martina .
TRANSPLANTATION, 2023, 107 (08) :1756-1763
[50]   Challenges in Long-Term Follow-Up Care of Patients After Kidney Transplantation in Specialized Transplant Centers [J].
Schiffer, Lena ;
Hartleib-Otto, Melanie ;
Lerch, Christian ;
Haller, Hermann ;
Pape, Lars ;
Schiffer, Mario .
GESUNDHEITSWESEN, 2020, 82 (11) :890-893